OneSoft Solutions Inc V.OSS

RE:Planet Microcap in Las Vegas

[Possibleidiot01]

https://stocksandstones.substack.com/p/preview-planet-microcap-showcase

Preview: Planet MicroCap Showcase 2024

Viva Las Vegas!

Mathieu Martin

Apr 17, 2024

 

 

 

From April 30 to May 2, I’ll attend the Planet MicroCap Showcase conference in Las Vegas with my analyst at Rivemont.

I’ve been attending this conference for several years and really enjoy the two-and-a-half-day format. On the first half-day, you hear keynote speeches, followed by company presentations and one-on-one meetings on the remaining two days.

Close to 100 presenting companies are involved in this year’s edition, including 21 Canadian companies.

On May 1, I will be moderating six fireside Q&A sessions with some of my favourite Canadian companies:

• Biorem (TSX-V: BRM)

• BioSyent (TSX-V: RX)

• BQE Water (TSX-V: BQE)

• OneSoft Solutions (TSX-V: OSS)

• Sabio Holdings (TSX-V: SBIO)

• Yerba Brands (TSX-V: YERB-U)

All the company presentations, including the fireside Q&A sessions, will be broadcast live through the online portal, so I encourage you to register and check it out.

On the last day, my analyst and I will sit down with 18 companies for 30-minute one-on-one meetings. Yes, it will be a gruelling day! (but hopefully very productive)

We typically meet companies for one of three reasons:

1. The Rivemont MicroCap Fund owns the stock, and we want to catch up with management (5 out of 18 meetings).

2. We are actively researching the company to potentially add it to the portfolio (5 out of 18 meetings)

3. We want to connect with the company for the first time and get to know management a little more (8 out of 18 meetings).

I’ll highlight one opportunity in each category to give you a flavour of the meetings I’ll be taking.

1. Biorem (TSX-V: BRM)

Biorem is a leading clean technology company that designs, manufactures and distributes a comprehensive line of high-efficiency air emissions control systems used to eliminate odours, volatile organic compounds, and hazardous air pollutants.

The company recently published phenomenal results for its fourth quarter of 2023, earning $0.15 per share in one quarter alone (the stock currently trades below $2.00). Given the $50-million backlog, it looks like 2024 could be another breakout year for Biorem. I’ll be looking to learn more about the expected timeline to deliver this backlog and details on the sales pipeline to replenish this backlog over the coming years.

2. McCoy Global (TSX: MCB)

McCoy is transforming well construction in the energy industry using automation and machine learning to maximize wellbore integrity and collect precise connection data.

McCoy is another company that reported very strong results a month ago. For 2023, revenue and adjusted EBITDA were up 33% and 54%, respectively, compared to the previous year. McCoy has a comfortable net cash position ($15.7 million) and currently trades at an EV/EBITDA multiple of less than 3 times based on 2023 results. The company is actively developing new technologies to improve its competitive position and fuel its growth. My only concern, obviously, is the cyclicality associated with the oil & gas industry.

3. Urban Infrastructure Group (TSX-V: UIG)

Urban is a construction company building foundational infrastructure for new homes in Ontario. The company went public via RTO less than a month ago, so I wasn’t familiar with them. Although I’m not overly excited about construction in general, the company benefits from tailwinds due to increasing immigration in Canada and the shortage of housing and skilled labour. Oh, and I forgot to mention that the company is growing and profitable. I definitely want to know more.

If you plan to attend the conference in person, hit me up and let’s find some time to connect!

I’ll make a recap to share the key takeaways and most exciting insights after the conference.

Stay tuned!

---

Thanks for reading Stocks & Stones! Subscribe for free to receive new posts in your inbox.

 

 

Disclaimer

This publication is for informational purposes only. Nothing produced under the Stocks & Stones brand should be construed as investment advice or recommendations. Mathieu Martin, the author, is employed as a Portfolio Manager with Rivemont Investments. This publication only represents Mathieu Martin’s own opinions and not those of Rivemont. Rivemont may own positions and transact on any securities mentioned in this publication at any time without prior notice. At the time of this writing, the Rivemont MicroCap Fund holds positions in Biorem (TSX-V: BRM), BioSyent (TSX-V: RX), BQE Water (TSX-V: BQE), OneSoft Solutions (TSX-V: OSS), Sabio Holdings (TSX-V: SBIO), and Yerba Brands (TSX-V: YERB-U). Always do your own research and consult a professional before making investment decisions.